InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 277753

Friday, 12/02/2016 11:18:30 PM

Friday, December 02, 2016 11:18:30 PM

Post# of 345700
Undisclosed Targets re: Immunotherapy

Seems likethere is a growing list of biotechs that fail to mention their targets / MOA .... and since we know that PS Targeting allows for that adaptive immune response... I guess it is time to keep an eye out for and Peregrine Pharmaceuticals hopefully taking precautionary measures now, not later

1) Agenus

http://agenusbio.com/pipeline/
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123355820

2) Moderna

http://www.modernatx.com/pipeline

3) Evotec

Edison Investment Research ... owns EvoTech, where Troy Luster working with now out of Dana Farber and they have listed here a few drugs not being disclosed:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106231165

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News